Stockreport

Supernus to Acquire CNS Portfolio from US WorldMeds

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF  Expands and strengthens neurology portfolio with three marketed CNS products and late-stage pipelineDiversifies revenue and operating cash flow base with 2019 net sales [Read more]